4DMedical Limited (ASX:4DX)

Market Cap	2.43B
Revenue (ttm)	5.85M
Net Income (ttm)	-30.07M
Shares Out	535.66M
EPS (ttm)	-0.14
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,670,981
Average Volume	7,908,488
Open	4.50
Previous Close	4.53
Day's Range	4.45 - 5.08
52-Week Range	0.23 - 5.08
Beta	2.93
RSI	73.93
Earnings Date	Feb 26, 2026

About 4DMedical

4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non‑invasive respiratory imaging solution using four‑dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function imaging software; IQ-UIP, a state-of-the-art software; LDAf, Patented Parametric Response Mapping (PRM) technology; LDAi, an automated detection of poten...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2012
• Employees: 124
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: 4DX

Financial Performance

In 2025, 4DMedical's revenue was 5.85 million, an increase of 55.91% compared to the previous year's 3.75 million. Losses were -30.07 million, -16.42% less than in 2024.